# Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus

> **NCT01545024** · — · UNKNOWN · sponsor: **Nagaoka Red Cross Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sitagliptin, 50 mg once per day per os

## Key facts

- **NCT ID:** NCT01545024
- **Lead sponsor:** Nagaoka Red Cross Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01545024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01545024, "Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01545024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*